VAM
IPCI

Verity Asset Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Verity Asset Management’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,000
Closed -$13K – 149
2018
Q2 		$13K Hold
3,000
– – 0.01% 114
2018
Q1 		$17K Hold
3,000
– – 0.02% 120
2017
Q4 		$24K Hold
3,000
– – 0.02% 130
2017
Q3 		$28K Buy
+3,000
New +$42.8K 0.02% 123

Other funds holding IPCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
FANJ
Financial Architects (New Jersey) Marlton, New Jersey $663M AUM 15.53% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Verity Asset Management's IPCI Position: Q3 2018 in Review

Verity Asset Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q3 2018, closing a stake of 3,000 shares — an estimated $13K sold.

Verity Asset Management first reported a position in IPCI in Q3 2017 and held it in 4 quarters. The position peaked at $28K in Q3 2017. 10 funds tracked by Wall St. Rank hold IPCI as of Q3 2018.

  • Verity Asset Management reported no remaining Intellipharmaceuticals International Inc. position as of Q3 2018 after selling out during the quarter.
  • Verity Asset Management sold 3,000 Intellipharmaceuticals International Inc. shares in Q3 2018, an estimated $13K.
  • Verity Asset Management first reported a position in Intellipharmaceuticals International Inc. in Q3 2017 and held it in 4 quarters.
  • Verity Asset Management's Intellipharmaceuticals International Inc. position peaked at $28K in Q3 2017.
  • 10 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q3 2018.

Based on Verity Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.